We use a patented Artificial Intelligence protocol for the treatment of Alzheimer's. In the study of the protocol, 75% of the patients had no further decline in their mild cognitive impairment. Some even had improvement. These are amazing results. We have a proprietary database on drug to drug interactions that can cause cognitive impairment.
We have perfected our approach using telemedicine as much as possible. We are now pivoting to a brick and mortar approach because we are dealing with seniors who are more comfortable that way. Mix of insurance coverage and cash programs.